Excimer Laser for Revascularisation of Saphenous Vein Grafts

Ebersole, Douglas G.

doi:10.1007/pl00011346

Cited by 18 publications

(10 citation statements)

References 34 publications

(39 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Historically laser angioplasty was developed to modify atherosclerotic plaque as an adjunct to balloon angioplasty [14][15][16][17][18][19][20][21][22][23][24]. As described in this series, the application of ELCA in contemporary PCI has changed significantly.…”

Section: Discussionmentioning

confidence: 99%

Excimer Laser Coronary Angioplasty: Clinical Applications and Procedural Outcome, in a Large-Volume Tertiary Centre

2021

View full text Add to dashboard Cite

Excimer-laser coronary angioplasty can be used to modify undilatable and uncrossable lesions in native arteries and in-stent restenosis which are increasingly encountered with the ageing population undergoing coronary intervention. We present our laser experience over a 10-year period in a large cardiac tertiary centre. Method: Retrospective analysis of prospectively collected data on all procedures where laser was used from August 2008 to December 2019. Clinical presentation, demographics, and procedural details were all recorded. Successful procedures were defined as <30% stenosis at the end. Periprocedural and in-hospital complications were recorded and verified. Results are presented as numbers and percentages. Results: A total of 331 patients were identified with 473 lesions treated with laser and an overall total of 637 lesions. Of the 473 lesions treated, 46 (9.9%) were in-stent restenosis, 146 (30.9%) were chronic total occlusions, and the rest were uncrossable or undilatable lesions. The vast majority of procedures (97.0%) were performed with the 0.9-mm laser catheter. The overall success rate was 81.6% (58–87%) from low- to high-volume user. Complications included dissection 3 (0.6%), no-reflow 3 (0.6%), coronary perforation 13 (2.7%), and tamponade in 1 (0.2%). Only 3 (0.6%) of the perforations were seen after the laser catheter passage, the rest were seen later following balloon preparation or stent insertion. Conclusion: Laser is a valuable tool for treating complex and resistant coronary lesions. Its efficacy and safety are well established and when applied appropriately, it helps to achieve optimal outcomes for our patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Excimer Laser Coronary Angioplasty: Clinical Applications and Procedural Outcome, in a Large-Volume Tertiary Centre

2021

View full text Add to dashboard Cite

show abstract

“…In our study, procedural results for ELCA were at least on a par with those obtained by balloon angioplasty and stent implantation alone. With regard to common angiographic parameters (TIMI flow, minimal luminal diameter, and diameter stenosis) results were in line with previous, non-randomized data [7,[9][10][11][12][20][21][22]. In addition, the quantitative measurement of epicardial blood flow velocity was assessed by the corrected TIMI frame count (cTFC) [16].…”

Section: Discussionmentioning

confidence: 99%

Excimer laser thrombus elimination for prevention of distal embolization and no-reflow in patients with acute ST elevation myocardial infarction

Dörr

Vogelgesang

Hummel

et al. 2007

International Journal of Cardiology

View full text Add to dashboard Cite

“…ELCA is a safer alternative, allowing predictable debulking during SVG-PCI. 48,49 The low rate of distal embolisation during ELCA of degenerative bypass grafts (1-5 %) may preclude the need for routine DPD in the majority of cases. 48 However, OCT images post-SVG ELCA make it is clear that there remains friable fragments that could embolise and cause no-reflow.…”

Section: Saphenous Vein Graftsmentioning

confidence: 99%

Coronary Intervention with the Excimer Laser: Review of the Technology and Outcome Data

Rawlins

Din

Talwar

et al. 2016

Interventional Cardiology Review

View full text Add to dashboard Cite

Excimer laser coronary atherectomy (ELCA) is a long-established adjunctive therapy that can be applied during percutaneous coronary intervention (PCI). Technical aspects have evolved and there is an established safety and efficacy record across a number of clinical indications in contemporary interventional practice where complex lesions are routinely encountered. The role of ELCA during PCI for thrombus, non-crossable or non-expandable lesions, chronic occlusions and stent under-expansion are discussed in this review.The key advantage of ELCA over alternative atherectomy interventions is delivery on a standard 0.014-inch guidewire. Additionally, the technique can be mastered by any operator after a short period of training. The major limitation is presence of heavy calcification although when rotational atherectomy (RA) is required but cannot be applied due to inability to deliver the dedicated RotaWire TM (Boston Scientific), ELCA can create an upstream channel to permit RotaWire passage and complete the case with RA -the RASER technique. KeywordsExcimer laser coronary atherectomy (ELCA); percutaneous coronary intervention (PCI); non-crossable lesions; chronic total occlusions (CTO); intra-coronary thrombus; under-expanded stents; rotational atherectomy (RA) Disclosure: ST and PO are European Proctors for Spectranetics. JR and JD have no conflicts of interest to declare.

show abstract

Excimer Laser for Revascularisation of Saphenous Vein Grafts

Cited by 18 publications

References 34 publications

Excimer Laser Coronary Angioplasty: Clinical Applications and Procedural Outcome, in a Large-Volume Tertiary Centre

Excimer Laser Coronary Angioplasty: Clinical Applications and Procedural Outcome, in a Large-Volume Tertiary Centre

Excimer laser thrombus elimination for prevention of distal embolization and no-reflow in patients with acute ST elevation myocardial infarction

Coronary Intervention with the Excimer Laser: Review of the Technology and Outcome Data

Contact Info

Product

Resources

About